A liquid biopsy is a minimally invasive test that detects cancer-related information from a blood sample. Unlike traditional biopsies that require a tissue sample from the tumor, liquid biopsies analyze circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and other biomarkers in the blood. This method offers a real-time snapshot of the cancer’s genetic landscape.